Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: A multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Marcelo E. Bigal, Lars Edvinsson, Alan M. Rapoport, Richard B. Lipton, Egilius L.H. Spierings, Hans Christoph Diener, Rami Burstein, Pippa S. Loupe, Yuju Ma, Ronghua Yang, Stephen D. Silberstein

Research output: Contribution to journalArticlepeer-review

203 Scopus citations

Fingerprint

Dive into the research topics of 'Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: A multicentre, randomised, double-blind, placebo-controlled, phase 2b study'. Together they form a unique fingerprint.

Medicine & Life Sciences